TREA

88439326 - AZURITY

Follow

Information

  • Trademark
  • 88439326
  • Serial Number
    88439326
  • Registration Number
    6196161
  • Filing Date
    May 21, 2019
    5 years ago
  • Registration Date
    November 10, 2020
    3 years ago
  • Transaction Date
    September 24, 2023
    11 months ago
  • Status Date
    November 10, 2020
    3 years ago
  • Published for Opposition Date
    March 03, 2020
    4 years ago
  • Location Date
    October 07, 2020
    3 years ago
  • First Use Anywhere Date
    August 31, 2020
    4 years ago
  • First Use In Commerce Date
    August 31, 2020
    4 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    DIBLE, JONATHON I
  • Attorney Docket Number
    C10472002900
    Attorney Name
    Douglas R. Wolf
    Law Office Assigned Location Code
    M20
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
AZURITY
Case File Statements
  • GS0051: Pharmaceutical preparations sold as a kit for use by pharmacists and physicians in creating compounded hormone replacement medicines, topical anti-inflammatory and ultrasound gels, pain and gastrointestinal disorders treatment medicines, and anti-inflammatory, antimicrobial, and antifungal treatment medicines; medicines for the treatment of cardiovascular diseases and disorders, colitis, muscle spasm, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders; antibiotics; pharmaceutical products for the treatment of pain, thyroid disorders, gastrointestinal disorders, gastroesophageal disorders, inflammation, infections, fungal diseases and disorders, cardiovascular diseases and disorders, colitis, muscle spasm, attention deficit hyperactivity disorders, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders having vancomycin, enalapril, lisinopril, and methotrexate as the active pharmaceutical ingredient; antacids; muscle relaxants; hormone replacement medicines; topical anti-inflammatory and ultrasound gels; pharmaceutical preparation for the treatment of pain, thyroid disorders, gastrointestinal disorders, gastroesophageal disorders, inflammation, infections, fungal diseases and disorders, cardiovascular diseases and disorders, colitis, muscle spasm, attention deficit hyperactivity disorders, infectious diseases, acid-reflux disease, ulcer disease, and urological disorders; pharmaceuticals for use in the treatment of cancer and autoimmune diseases and disorders, and for the treatment and prevention of renal, oncological, inflammatory, gastrointestinal, gastroesophageal, and cardio-vascular diseases and disorders
Case File Event Statements
  • 11/10/2020 - 3 years ago
    22 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 10/8/2020 - 3 years ago
    21 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 10/7/2020 - 3 years ago
    20 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 10/2/2020 - 3 years ago
    19 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 9/17/2020 - 4 years ago
    18 - USE AMENDMENT FILED Type: IUAF
  • 10/2/2020 - 3 years ago
    17 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 9/17/2020 - 4 years ago
    16 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 4/29/2020 - 4 years ago
    15 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 4/28/2020 - 4 years ago
    14 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 3/3/2020 - 4 years ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/3/2020 - 4 years ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/12/2020 - 4 years ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/30/2020 - 4 years ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/29/2020 - 4 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/29/2020 - 4 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/29/2020 - 4 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/9/2019 - 5 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 8/9/2019 - 5 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 8/9/2019 - 5 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/8/2019 - 5 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/5/2019 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/24/2019 - 5 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP